Corina Amor Vegas
CSHL Fellow
Cancer Center Member
M.D., Ph.D., Gerstner Sloan Kettering Graduate School of Biomedical Sciences, 2021
amor@cshl.edu | 516-367-5504
As we age our body accumulates damaged “senescent” cells that our immune system is no longer able to effectively eliminate. Senescent cells are responsible for the development of aging and age-related diseases like cancer or fibrosis. My group studies how senescent cells evade the immune system thereby identifying new therapeutic approaches.
Our lab studies cellular senescence. Senescence is a stress response program that is triggered in damaged cells and leads to their elimination by the immune system. If uncleared, the accumulation of senescent cells generates a chronic pro-inflammatory microenvironment that conduces to aging and tumor development. We seek to understand how the immune system recognizes and targets these cells in physiological conditions and how senescent cells evade immune clearance in disease. We aim to leverage our findings to develop immune-based therapeutic approaches to target senescent cells in cancer, aging and age-related pathologies. In our studies we develop and combine novel somatic mouse models of cancer and cell-based therapeutics such as our recently developed senolytic CAR T cells.
President’s essay: Bringing bold visions to life
May 26, 2023
CSHL President & CEO Bruce Stillman sees the Laboratory as a global hub for scientific expertise and a powerful launchpad for early-career scientists.
MWCABC donates $75,000 to CSHL’s Dr. Corina Amor
January 18, 2023
Members of the Manhasset Women's Coalition Against Breast Cancer presented a $75,000 check to CSHL's Dr. Corina Amor to support her research.
Cold Spring Harbor Laboratory: Foundations for the Future
December 15, 2022
CSHL continues to lead in biomedical sciences by fostering a collaborative, innovative, and high-risk, high-reward research community.
Amor Vegas wins NIH Director’s Early Independence Award
October 4, 2022
The 2022 award, given to only 14 investigators, will support her pioneering research on the aging process.
Corina Amor named in Forbes 30 Under 30 Europe list for 2022
May 16, 2022
Corina Amor, a CSHL Fellow and Cancer Center member, has been named a top entrepreneur and scientist in Forbes 30 Under 30 Europe list.
All Publications
Senolytic CAR T cells reverse senescence-associated pathologies.
17 Jul 2020 | Nature | 583(7814):127-132
Amor, Corina, Feucht, Judith, Leibold, Josef, Ho, Yu-Jui, Zhu, Changyu, Alonso-Curbelo, Direna, Mansilla-Soto, Jorge, Boyer, Jacob, Li, Xiang, Giavridis, Theodoros, Kulick, Amanda, Houlihan, Shauna, Peerschke, Ellinor, Friedman, Scott, Ponomarev, Vladimir, Piersigilli, Alessandra, Sadelain, Michel, Lowe, Scott
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis.
Jul 2020 | Cancer Discovery | 10(7):1038-1057
Leibold, Josef, Ruscetti, Marcus, Cao, Zhen, Ho, Yu-Jui, Baslan, Timour, Zou, Min, Abida, Wassim, Feucht, Judith, Han, Teng, Barriga, Francisco, Tsanov, Kaloyan, Zamechek, Leah, Kulick, Amanda, Amor, Corina, Tian, Sha, Rybczyk, Katarzyna, Salgado, Nelson, Sánchez-Rivera, Francisco, Watson, Philip, de Stanchina, Elisa, Wilkinson, John, Dow, Lukas, Abate-Shen, Cory, Sawyers, Charles, Lowe, Scott
Convergent transcription at intragenic super-enhancers targets AID-initiated genomic instability.
18 Dec 2014 | Cell | 159(7):1538-48
Meng, Fei-Long, Du, Zhou, Federation, Alexander, Hu, Jiazhi, Wang, Qiao, Kieffer-Kwon, Kyong-Rim, Meyers, Robin, Amor, Corina, Wasserman, Caitlyn, Neuberg, Donna, Casellas, Rafael, Nussenzweig, Michel, Bradner, James, Liu, X, Alt, Frederick